Related Experiment Videos
The designer drug situation in Ibiza
C Lora-Tamayo1, T Tena, A Rodríguez
1Instituto Nacional de Toxicología, Ministerio de Justicia, C/ Luis Cabrera 9, Madrid 28002, Spain. c.lora-tamayo@mju.es
Forensic Science International
|March 24, 2004
Summary
Designer drug use in Ibiza is prevalent, with methylenedioxymethamphetamine (MDMA) being the most common. Combining MDMA with other substances increases the likelihood of severe toxic symptoms requiring emergency medical care.
Area of Science:
- Forensic Toxicology
- Clinical Chemistry
- Drug Abuse Research
Background:
- Designer drug consumption is a growing public health concern.
- Understanding the prevalence and patterns of designer drug use is crucial for public health interventions.
- Ibiza has been identified as a location with significant designer drug use.
Purpose of the Study:
- To determine the prevalence of various designer drugs in Ibiza.
- To identify the most commonly used designer drugs and their combinations.
- To investigate the association between designer drug use and the need for emergency medical care.
Main Methods:
- Analysis of 137 urine and 46 serum samples from 154 self-confessed designer drug users.
- Detection of designer drugs including amphetamine derivatives (e.g., MDMA), ketamine, and gamma-hydroxybutyric acid.
- Correlation of drug presence with clinical presentation and emergency room attendance.
Main Results:
- 99 out of 154 individuals tested positive for designer drugs.
- Methylenedioxymethamphetamine (MDMA) was the most prevalent designer drug, used alone or in combination.
- Mixtures of MDMA with other drugs, ethanol, or cocaine were associated with increased toxic symptoms and emergency room visits.
Conclusions:
- MDMA is a significant designer drug of concern in Ibiza.
- Polysubstance use involving MDMA poses a higher risk for acute toxicity.
- Toxicological analysis of drug metabolites, such as HMMA, is important for clinical interpretation.